vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and RBB Bancorp (RBB). Click either name above to swap in a different company.

ARVINAS, INC. is the larger business by last-quarter revenue ($41.9M vs $32.3M, roughly 1.3× RBB Bancorp). RBB Bancorp runs the higher net margin — 31.5% vs -83.8%, a 115.3% gap on every dollar of revenue. On growth, RBB Bancorp posted the faster year-over-year revenue change (12.6% vs -59.1%). RBB Bancorp produced more free cash flow last quarter ($42.6M vs $-59.2M). Over the past eight quarters, ARVINAS, INC.'s revenue compounded faster (10.0% CAGR vs 7.0%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

RBB Bancorp is a US-based financial holding company that operates Royal Business Bank as its primary banking subsidiary. It caters mainly to Asian American communities, small and medium-sized enterprises, real estate investors, and retail clients, offering comprehensive commercial banking, consumer lending, deposit services, and wealth management solutions across branches in key US coastal metropolitan areas.

ARVN vs RBB — Head-to-Head

Bigger by revenue
ARVN
ARVN
1.3× larger
ARVN
$41.9M
$32.3M
RBB
Growing faster (revenue YoY)
RBB
RBB
+71.7% gap
RBB
12.6%
-59.1%
ARVN
Higher net margin
RBB
RBB
115.3% more per $
RBB
31.5%
-83.8%
ARVN
More free cash flow
RBB
RBB
$101.8M more FCF
RBB
$42.6M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
ARVN
ARVN
Annualised
ARVN
10.0%
7.0%
RBB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
RBB
RBB
Revenue
$41.9M
$32.3M
Net Profit
$-35.1M
$10.2M
Gross Margin
Operating Margin
-104.5%
39.5%
Net Margin
-83.8%
31.5%
Revenue YoY
-59.1%
12.6%
Net Profit YoY
28.7%
132.1%
EPS (diluted)
$-0.48
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
RBB
RBB
Q4 25
$32.3M
Q3 25
$41.9M
$32.6M
Q2 25
$35.8M
Q1 25
$188.8M
$28.5M
Q4 24
$59.2M
$28.7M
Q3 24
$102.4M
$30.3M
Q2 24
$76.5M
$27.5M
Q1 24
$25.3M
$28.2M
Net Profit
ARVN
ARVN
RBB
RBB
Q4 25
$10.2M
Q3 25
$-35.1M
$10.1M
Q2 25
$9.3M
Q1 25
$82.9M
$2.3M
Q4 24
$-45.1M
$4.4M
Q3 24
$-49.2M
$7.0M
Q2 24
$-35.2M
$7.2M
Q1 24
$-69.4M
$8.0M
Operating Margin
ARVN
ARVN
RBB
RBB
Q4 25
39.5%
Q3 25
-104.5%
40.7%
Q2 25
36.1%
Q1 25
37.8%
11.2%
Q4 24
-98.1%
17.6%
Q3 24
-58.9%
31.6%
Q2 24
-63.4%
35.6%
Q1 24
-329.2%
39.9%
Net Margin
ARVN
ARVN
RBB
RBB
Q4 25
31.5%
Q3 25
-83.8%
31.2%
Q2 25
26.1%
Q1 25
43.9%
8.0%
Q4 24
-76.2%
15.3%
Q3 24
-48.0%
23.1%
Q2 24
-46.0%
26.4%
Q1 24
-274.3%
28.4%
EPS (diluted)
ARVN
ARVN
RBB
RBB
Q4 25
$0.59
Q3 25
$-0.48
$0.59
Q2 25
$0.52
Q1 25
$1.14
$0.13
Q4 24
$-0.63
$0.26
Q3 24
$-0.68
$0.39
Q2 24
$-0.49
$0.39
Q1 24
$-0.97
$0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
RBB
RBB
Cash + ST InvestmentsLiquidity on hand
$787.6M
$212.3M
Total DebtLower is stronger
$600.0K
$119.9M
Stockholders' EquityBook value
$564.4M
$523.4M
Total Assets
$844.3M
$4.2B
Debt / EquityLower = less leverage
0.00×
0.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
RBB
RBB
Q4 25
$212.3M
Q3 25
$787.6M
$234.9M
Q2 25
$191.9M
Q1 25
$954.3M
$238.8M
Q4 24
$1.0B
$257.7M
Q3 24
$1.1B
$349.4M
Q2 24
$1.2B
$252.8M
Q1 24
$1.2B
Total Debt
ARVN
ARVN
RBB
RBB
Q4 25
$119.9M
Q3 25
$600.0K
$119.8M
Q2 25
$119.7M
Q1 25
$700.0K
$119.6M
Q4 24
$800.0K
$119.5M
Q3 24
$800.0K
$119.4M
Q2 24
$900.0K
$119.3M
Q1 24
$900.0K
$119.2M
Stockholders' Equity
ARVN
ARVN
RBB
RBB
Q4 25
$523.4M
Q3 25
$564.4M
$514.3M
Q2 25
$517.7M
Q1 25
$660.1M
$510.3M
Q4 24
$561.7M
$507.9M
Q3 24
$586.0M
$509.7M
Q2 24
$600.2M
$511.3M
Q1 24
$609.7M
$514.0M
Total Assets
ARVN
ARVN
RBB
RBB
Q4 25
$4.2B
Q3 25
$844.3M
$4.2B
Q2 25
$4.1B
Q1 25
$1.0B
$4.0B
Q4 24
$1.1B
$4.0B
Q3 24
$1.2B
$4.0B
Q2 24
$1.3B
$3.9B
Q1 24
$1.2B
$3.9B
Debt / Equity
ARVN
ARVN
RBB
RBB
Q4 25
0.23×
Q3 25
0.00×
0.23×
Q2 25
0.23×
Q1 25
0.00×
0.23×
Q4 24
0.00×
0.24×
Q3 24
0.00×
0.23×
Q2 24
0.00×
0.23×
Q1 24
0.00×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
RBB
RBB
Operating Cash FlowLast quarter
$-59.1M
$43.4M
Free Cash FlowOCF − Capex
$-59.2M
$42.6M
FCF MarginFCF / Revenue
-141.3%
131.8%
Capex IntensityCapex / Revenue
0.2%
2.5%
Cash ConversionOCF / Net Profit
4.26×
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$73.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
RBB
RBB
Q4 25
$43.4M
Q3 25
$-59.1M
$2.1M
Q2 25
$21.7M
Q1 25
$-88.9M
$7.8M
Q4 24
$-84.1M
$58.5M
Q3 24
$-128.0M
$24.5M
Q2 24
$50.3M
$11.7M
Q1 24
$-97.5M
$4.8M
Free Cash Flow
ARVN
ARVN
RBB
RBB
Q4 25
$42.6M
Q3 25
$-59.2M
$1.8M
Q2 25
$21.6M
Q1 25
$-89.3M
$7.6M
Q4 24
$-84.4M
$57.7M
Q3 24
$-128.7M
$24.2M
Q2 24
$49.6M
$11.5M
Q1 24
$-97.6M
$4.7M
FCF Margin
ARVN
ARVN
RBB
RBB
Q4 25
131.8%
Q3 25
-141.3%
5.4%
Q2 25
60.2%
Q1 25
-47.3%
26.7%
Q4 24
-142.6%
201.0%
Q3 24
-125.7%
80.0%
Q2 24
64.8%
42.0%
Q1 24
-385.8%
16.6%
Capex Intensity
ARVN
ARVN
RBB
RBB
Q4 25
2.5%
Q3 25
0.2%
1.1%
Q2 25
0.3%
Q1 25
0.2%
0.6%
Q4 24
0.5%
2.7%
Q3 24
0.7%
0.8%
Q2 24
0.9%
0.5%
Q1 24
0.4%
0.5%
Cash Conversion
ARVN
ARVN
RBB
RBB
Q4 25
4.26×
Q3 25
0.21×
Q2 25
2.32×
Q1 25
-1.07×
3.39×
Q4 24
13.34×
Q3 24
3.50×
Q2 24
1.61×
Q1 24
0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons